Latest Ratings for CLX Date Firm Action From To Feb 2022 DA Davidson Maintains Neutral Feb 2022 Barclays Maintains Underweight Feb 2022 Morgan Stanley Maintains Underweight View More Analyst Ratings for CLX View the Latest Analyst Ratings read more ​  ​Latest Ratings for CLX DateFirmActionFromTo Feb 2022DA DavidsonMaintainsNeutral Feb 2022BarclaysMaintainsUnderweight Feb 2022Morgan StanleyMaintainsUnderweight View More

Latest Ratings for MCHP Date Firm Action From To Mar 2022 UBS Maintains Buy Feb 2022 Rosenblatt Maintains Buy Jan 2022 UBS Upgrades Neutral Buy View More Analyst Ratings for MCHP View the Latest Analyst Ratings read more ​  ​Latest Ratings for MCHP DateFirmActionFromTo Mar 2022UBSMaintainsBuy Feb 2022RosenblattMaintainsBuy Jan 2022UBSUpgradesNeutralBuy View More Analyst Ratings for

Latest Ratings for RARE Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 JP Morgan Upgrades Neutral Overweight Feb 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for RARE View the Latest Analyst Ratings read more ​  ​Latest Ratings for RARE DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022JP MorganUpgradesNeutralOverweight Feb 2022Morgan

Latest Ratings for TCRX Date Firm Action From To Dec 2021 HC Wainwright & Co. Initiates Coverage On Buy Aug 2021 Cowen & Co. Initiates Coverage On Outperform Aug 2021 Morgan Stanley Initiates Coverage On Overweight View More Analyst Ratings for TCRX View the Latest Analyst Ratings read more ​  ​Latest Ratings for TCRX DateFirmActionFromTo

read more ​  ​read more 

Latest Ratings for ACLX Date Firm Action From To Mar 2022 SVB Leerink Initiates Coverage On Outperform Mar 2022 B of A Securities Initiates Coverage On Buy View More Analyst Ratings for ACLX View the Latest Analyst Ratings read more ​  ​Latest Ratings for ACLX DateFirmActionFromTo Mar 2022SVB LeerinkInitiates Coverage OnOutperform Mar 2022B of A

read more ​  ​read more 

read more ​  ​read more 

read more ​  ​read more 

read more ​  ​read more